https://www.selleckchem.com/products/erastin.html
In-hospital mortality or in-hospital mortality and/or ICU stay≥3 days were 17.3% and 21%, for qSOFA≥2 patients versus 4.7% and 6.9% for qSOFA2 patients (P.001). qSOFA≥2 had a negative predictive value of 95% for in-hospital mortality and 93% for in-hospital mortality or ICU stay≥3 days. Among oncology patients presenting to the ED with suspected infection, a qSOFA≥2 is associated with a threefold risk of hospital mortality/prolonged ICU stay. Its absence helps identify low-risk patients. Among oncology patients presenting to the
Like
Comment
Share
